Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Avadisian

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Biosystems|June 18, 2013
Extolling the benefits of molecular therapeutic lipidationMiriam Avadisian, Patrick T Gunning
Anti-Cancer Drugs|November 11, 2010
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress reportSina Haftchenary, Miriam Avadisian, Patrick T Gunning
Rheumatology and Therapy|December 24, 2025
Treatment Patterns and Clinical Outcomes for Patients Living with Active Giant Cell Arteritis in CanadaJean-Paul Makhzoum, Miriam Avadisian, Dalinda Liazoghli
Journal of Fluorescence|May 22, 2009
A photostable, pH-invariant fluorescein derivative for single-molecule microscopyBaoxu Liu, Steven Fletcher, Miriam Avadisian, et al.
The Journal of Dermatology|November 8, 2021
Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasisMelinda J Gooderham, Charles Lynde, Irina Turchin, et al.
Dermatology and Therapy|March 14, 2022
Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS)Charles W Lynde, Maryam S Alam, Kamal Ohson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Biosystems|June 18, 2013
Extolling the benefits of molecular therapeutic lipidationMiriam Avadisian, Patrick T Gunning
Anti-Cancer Drugs|November 11, 2010
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress reportSina Haftchenary, Miriam Avadisian, Patrick T Gunning
Rheumatology and Therapy|December 24, 2025
Treatment Patterns and Clinical Outcomes for Patients Living with Active Giant Cell Arteritis in CanadaJean-Paul Makhzoum, Miriam Avadisian, Dalinda Liazoghli
Journal of Fluorescence|May 22, 2009
A photostable, pH-invariant fluorescein derivative for single-molecule microscopyBaoxu Liu, Steven Fletcher, Miriam Avadisian, et al.
The Journal of Dermatology|November 8, 2021
Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasisMelinda J Gooderham, Charles Lynde, Irina Turchin, et al.
Dermatology and Therapy|March 14, 2022
Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS)Charles W Lynde, Maryam S Alam, Kamal Ohson, et al.
Pageof 1